High-risk groups and screening strategies for early detection of hepatocellular carcinoma in patients with chronic liver disease
- PMID: 8406298
High-risk groups and screening strategies for early detection of hepatocellular carcinoma in patients with chronic liver disease
Abstract
Characteristics of high-risk groups for hepatocellular carcinoma (HCC) in Japan were studied to establish screening strategies for early detection of the tumor. Some 93% of patients with HCC were associated with chronic liver disease. On the other hand, 67% of patients with liver cirrhosis had HCC at autopsy. Most were related to current hepatitis virus infection. An analysis of risk factors among 120 patients with chronic hepatitis revealed that age and histological findings were independent risk factors, while HBsAg, anti-HCV, sex, history of heavy drinking, history of blood transfusion were not independent risk factors. Multivariate analysis of 239 patients with liver cirrhosis demonstrated that age, positivity for HBsAg and/or anti-HCV, family history of liver disease, hepatic reserve, and a history of radical resection were independent factors related to the development of HCC. A screening schedule for cirrhotic patients was established in accordance with these results; ultrasonography was done every three months, and tumor markers measured every two months. The screening strategy proved to be effective for the early detection of HCC and improvement of the prognosis.
Similar articles
-
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11. doi: 10.1111/j.1440-1746.2007.04908.x. Epub 2007 Jun 7. J Gastroenterol Hepatol. 2007. PMID: 17559381
-
Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.Princess Takamatsu Symp. 1995;25:27-32. Princess Takamatsu Symp. 1995. PMID: 8875606 Review.
-
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.Cancer. 1999 May 15;85(10):2132-7. Cancer. 1999. PMID: 10326690
-
Hepatocellular carcinoma development in cirrhosis.Best Pract Res Clin Gastroenterol. 2007;21(1):161-73. doi: 10.1016/j.bpg.2006.07.002. Best Pract Res Clin Gastroenterol. 2007. PMID: 17223503 Review.
-
Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.Indian J Pathol Microbiol. 2006 Jul;49(3):357-61. Indian J Pathol Microbiol. 2006. PMID: 17001884
Cited by
-
Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma.PLoS One. 2016 Sep 20;11(9):e0163119. doi: 10.1371/journal.pone.0163119. eCollection 2016. PLoS One. 2016. PMID: 27649084 Free PMC article.
-
Advances in managing hepatocellular carcinoma.Front Med. 2014 Jun;8(2):175-89. doi: 10.1007/s11684-014-0332-4. Epub 2014 May 8. Front Med. 2014. PMID: 24810646 Review.
-
Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer.Ann Surg. 1995 Sep;222(3):375-80; discussion 380-3. doi: 10.1097/00000658-199509000-00014. Ann Surg. 1995. PMID: 7677466 Free PMC article.
-
Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.PLoS Med. 2014 Apr 1;11(4):e1001624. doi: 10.1371/journal.pmed.1001624. eCollection 2014 Apr. PLoS Med. 2014. PMID: 24691105 Free PMC article.
-
Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.Ann Surg. 1998 Apr;227(4):513-8. doi: 10.1097/00000658-199804000-00011. Ann Surg. 1998. PMID: 9563539 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical